MedTrace Logo

Role of Vitamin D Supplementation as an Adjuvant Therapy inTreatment of Helicobacter Pylori in Children

NCT05879237 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-05-30

No results posted yet for this study

Summary

To study the efficacy of vitamin D in conjunction with Helicobacter pylori treatment in children in eradication of helicobacter pylori.

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Vitamin D3

Vitamin D3 ,1000 unit ,once daily, oral, for 1 month plus triple therapy

DRUG

Helicobacter pylori triple therapy

Triple therapy which is: amoxcillin on 50 mg/kg/day for 2 weeks, Clarithromycin 20mg/kg/day for 2 weeks and proton pump inhibitor 3.ppi 1mg/kg/day for 1month

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Minia University

    lead OTHER

Principal Investigators

  • samir M mounir, ass prof · Minia University, faculty of medicine

  • Yosra M awad, lecturer · ain shams university .faculty of medicine

  • shimaa M yassin, ass lect · Minia University, faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-12-01
Completion
2023-12-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05879237 on ClinicalTrials.gov